Skip to main content
Clinical Trials/NCT05830929
NCT05830929
Recruiting
Not Applicable

Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients

Chinese University of Hong Kong1 site in 1 country100 target enrollmentAugust 1, 2023

Overview

Phase
Not Applicable
Intervention
Ovarian tissue freezing and subsequent auto-transplantation after thawing
Conditions
Neoplasms
Sponsor
Chinese University of Hong Kong
Enrollment
100
Locations
1
Primary Endpoint
Surgical complications
Status
Recruiting
Last Updated
3 months ago

Overview

Brief Summary

Ovarian Tissue Cryopreservation will be provided to cancer patients to allow them to have their fertility preserved.

Detailed Description

This project hopes to provide Ovarian Tissue Cryopreservation to patients who do not have adequate time for ovarian stimulation in oocyte or embryo freezing and in prepubertal girls where oocyte freezing is not possible. All the patients will have fertility preservation consultations with a fertility specialist in our unit to go through the details of ovarian Tissue Cryopreservation service and risks related to ovarian tissue cryopreservation procedures. After undergoing ovarian tissue collection via surgery, the collected ovarian tissue will be cryopreserved either by slow freezing or vitrification in our unit.

Registry
clinicaltrials.gov
Start Date
August 1, 2023
End Date
December 30, 2043
Last Updated
3 months ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chung Pui Wah Jacqueline

Associate Professor

Chinese University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Patients aged from 0-35 years old and diagnosed with cancer e.g., leukaemia, myeloproliferative or myelodysplastic diseases, lymphoma, bone tumours, neurological neoplasms and sarcoma, Paediatric bone marrow transplant patients
  • Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;
  • Patients suffering from hormone-sensitive malignancies who will undergo medical treatment, such as radiotherapy and chemotherapy that is liable to damage their ovaries and deter them from conception in the future.

Exclusion Criteria

  • Patients with no anticipated oncologic therapies
  • Patients who are pregnant
  • Children with one ovary
  • Children deemed high risk for perioperative complications
  • Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)

Arms & Interventions

Ovarian tissue freezing and subsequent auto-transplantation after thawing

Ovarian tissue freezing and subsequent auto-transplantation after thawing

Intervention: Ovarian tissue freezing and subsequent auto-transplantation after thawing

Outcomes

Primary Outcomes

Surgical complications

Time Frame: 15 years

Surgical complications after ovarian tissue transplantation

Secondary Outcomes

  • Pregnancy rate(15 years)

Study Sites (1)

Loading locations...

Similar Trials